Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure
- PMID: 27040168
- DOI: 10.1111/apt.13565
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure
Comment in
-
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure--authors' reply.Aliment Pharmacol Ther. 2016 May;43(9):1020. doi: 10.1111/apt.13579. Aliment Pharmacol Ther. 2016. PMID: 27040169 No abstract available.
Comment on
-
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.Aliment Pharmacol Ther. 2015 Apr;41(7):613-23. doi: 10.1111/apt.13083. Epub 2015 Feb 4. Aliment Pharmacol Ther. 2015. PMID: 25652884
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources